➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Boehringer Ingelheim
Johnson and Johnson
AstraZeneca
Moodys

Last Updated: May 6, 2021

DrugPatentWatch Database Preview

Barr Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for BARR, and what generic and branded alternatives to BARR drugs are available?

BARR has one hundred and seventy-four approved drugs.

There are seven tentative approvals on BARR drugs.

Summary for Barr
US Patents:0
Tradenames:121
Ingredients:95
NDAs:174
Patent Litigation for Barr: See patent lawsuits for Barr

Drugs and US Patents for Barr

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 083687-001 Approved Prior to Jan 1, 1982 DISCN No No   Get Started for $10   Get Started for $10
Barr Labs Inc METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 079031-002 Jul 13, 2012 DISCN No No   Get Started for $10   Get Started for $10
Barr HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 040307-004 Jul 26, 2000 DISCN No No   Get Started for $10   Get Started for $10
Barr MEPROBAMATE meprobamate TABLET;ORAL 084230-001 Approved Prior to Jan 1, 1982 DISCN No No   Get Started for $10   Get Started for $10
Barr MECLOFENAMATE SODIUM meclofenamate sodium CAPSULE;ORAL 072809-001 Mar 20, 1989 DISCN No No   Get Started for $10   Get Started for $10
Barr E-BASE erythromycin TABLET, DELAYED RELEASE;ORAL 062999-001 Nov 25, 1988 DISCN No No   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
McKesson
Merck
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.